Cannabidiol, a non-intoxicating derivative from cannabis, has been shown to reduce seizures and autism-like behaviors in a mouse model of a genetic disorder, Dravet syndrome. Children with this devastating condition have difficult-to-treat epilepsy, cognitive impairments, and problems with social interactions. The researchers also studied how therapeutic effects of cannabidiol relate to changes in signaling between certain brain neurons.